Active Stocks
Mon Apr 28 2025 15:57:17
  1. Reliance Industries share price
  2. 1,368.50 5.27%
  1. State Bank Of India share price
  2. 817.60 2.36%
  1. Tata Steel share price
  2. 142.05 2.42%
  1. Tata Motors share price
  2. 668.35 2.06%
  1. Itc share price
  2. 428.80 0.15%
Business News/Market/Market Stats/    Alembic Pharmaceuticals

ALEMBIC PHARMACEUTICALS SUMMARY

Alembic Pharmaceuticals is trading 0.29% lower at Rs 872.95 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 886.00 & 866.45. Alembic Pharmaceuticals has given -17.89% in this year & 3.01% in the last 5 days.

 

Alembic Pharmaceuticals has TTM P/E ratio 34.72 as compared to the sector P/E of 26.62. There are 9 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 138.42 Crores in its last quarter.

 

Listed peers of Alembic Pharmaceuticals include Wockhardt (-0.24%), Eris Lifesciences (0.73%), Alembic Pharmaceuticals (-0.29%) etc.

 

Alembic Pharmaceuticals has a 69.67% promoter holding & 30.33% public holding.

FAQs about Alembic Pharmaceuticals

Alembic Pharmaceuticals is trading at 872.95 as on 28 Apr, 2025 3:29:36 PM. This is -0.29% lower as compared to its previous closing price of 875.45
The market capitalization of Alembic Pharmaceuticals is 17070.26 Cr as on 28 Apr, 2025 3:29:36 PM.
The average broker rating on Alembic Pharmaceuticals is Hold. The breakup of analyst rating is given below -
  • 1 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 5 analysts have given a hold rating
  • 1 analysts have given a buy rating
  • 2 analysts have given a strong buy rating
The 52 wk high for Alembic Pharmaceuticals is 1296.15 whereas the 52 wk low is 725.60
Alembic Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 34.72
  • Sector P/E: 26.62
  • Dividend Yield: 1.26%
  • D/E ratio: -
Alembic Pharmaceuticals reported a net profit of 615.83 Cr in 2024.
Recommended For You